CARE Ratings Limited announces Q2 FY27 results, interim dividend, and board appointment
CARE Ratings · Capital Markets
What the filing says
- Approved unaudited standalone and consolidated financial results for quarter and half year ended September 30, 2026.
- Declared interim dividend of ₹10 per equity share for FY 2026-27, record date November 6, 2026.
- Appointed Mr. Jatindar Pal Singh Bajaj as Additional Non-Executive Non-Independent Director effective October 29, 2026.
Why it's rated notable: the year-on-year change is 26% (20% to 50%)
Original filing
Board Meeting Outcome for Outcome Of The Board Meeting
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from CARE Ratings
- Financial resultsNotableCARE Ratings Q2 FY 26-27 results, Rs 10 interim dividend, new additional director
Other dividend / buyback / bonus filings this fortnight
- Alldigi Tech Q2 profit rises to ₹2,658 lakhs; board approves ₹48 crore buyback
- Alldigi Tech Limited announces Q2 FY27 results and approves ₹48 crore buyback
- Alldigi Tech reports Q2 FY27 PAT up 50.9%, EBITDA up 28.5%, margin expands to 30.2%
- Kaveri Seed Company Limited announces Q2 2026 results, interim dividend, and new CFO
- Kaveri Seed Company Limited announces Q2 results, interim dividend, and CFO appointment
- Vedanta Limited reports record Q2 and H1 FY27 results; Q2 PAT up 151% YoY
Potential multibaggers · Q2 FY27
Potential multibaggers in Capital Markets
on management's own guidance
- Nippon Life Ind.Good growth2
- BSEGood growth1
- Motil.Oswal.Fin.Good growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.